Existing USFDA-approved drug shows promise for two rare genetic disorders: researchers
Ahmedabad Mirror|November 28, 2024
A team of Canadian researchers has found an existing US Food and Drug Administration-approved drug that could significantly improve the quality of life for patients affected with Sandhoff and Tay-Sachs diseases—two rare genetic disorders.
Existing USFDA-approved drug shows promise for two rare genetic disorders: researchers

Sandhoff and Tay-Sachs diseases cause progressive damage to nerve cells in the brain and spinal cord; there is currently no cure for both disorders.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.